Abstract:Background We hypothesised that mesenchymal stem cells (MSCs) overexpressing Cellular Repressor of E1A-stimulated Genes (CREG) showed improved survival and engraftment in the infarcted heart and promoted vascularisation through paracrine release of vascular endothelial growth factor (VEGF) and activation of the HIF-1α signal pathway. Methods Mononuclear cells derived from rat bone marrow were isolated by density-gradient centrifugation and were cultured on fibronectin-coated plates, supplied with bovine pituitary extract. After the marrow-derived mesenchymal stem cells over-expressed CREG, we compare with the production of VEGF by ELISA and the protein expression of HIF-1α in different groups by western blot under hypoxia. Rat bone marrow–derived MSCs were used as nontransduced (NormMSCs) or transduced with adenoviral-GFP vector (GFPMSCs) or vector encoding for GFP-CREG (CREGMSCs). Results For in vivo studies, 50 μl of DMEM without cells (group 1) or containing 1.5×106NormMSCs (group 2) or GFPMSCs (group 3) or CREGMSCs (group 4) were implanted intramyocardially in rat model of permanent coronary artery occlusion. one week later, immunoblot on rat heart tissue (n = 4 per group) showed highest survival of CREGMSCs (p < 0.06 vs NormMSCs and GFPMSCs)(n = 6 per group). Confocal imaging after immunostaining for CD31 showed extensive angiomyogenesis in the infarcted heart. Infarction size was significantly reduced in cell transplanted groups compared with the control. Indices of left ventricular function, including ejection fraction and fractional shortening, were improved in group 4 as compared with group 1 (p < 0.05). In vitro, under hypoxia the secretion of VEGF are most in the supernatant from the MSCs over-expression CREG. And the supernatants from BMSC over-expressed CREG exhibited a significant increase in angiogenic tube formation. In addition, the expression of CREG begins to appear after hypoxia. Molecular studies revealed that under hypoxia CREG active HIF-1α, but not HIF-2α, HIF-1β and we use the inhibition of HIF-1α confirm it. Further, we found that CREG can not influence the HIF-1α mRNA synthesis but it can inhibit the expression of pVHL which is the key protein regulation degradation of HIF-1α. Conclusions The strategies of CREG transgene expression inhibit pVHL and induced HIF-1α signalling and culminated in extensive angiomyogenesis in the infarcted heart.

OVEREXPRESSING CELLULAR REPRESSOR OF E1A-STIMULATED GENES PROTECTS MESENCHYMAL STEM CELLS AGAINST HYPOXIA- AND SERUM DEPRIVATION-INDUCED APOPTOSIS BY ACTIVATION OF PI3K/AKT

Overexpression of Cellular Repressor of E1A-stimulated Genes Inhibits TNF-α-induced Apoptosis Via NF-κB in Mesenchymal Stem Cells

Cellular Repressor of E1A-stimulated Gene Overexpression in Bone Mesenchymal Stem Cells Protects Against Rat Myocardial Infarction.

Heregulin Protects Mesenchymal Stem Cells from Serum Deprivation and Hypoxia-Induced Apoptosis

ASSA14-03-23 CREG Over-Expression in BMSC Protect Against Myocardial Infarction Via VHL/HIF-1α/VEGF Pathway Mediated Vascularisation

Protective Paracrine Effect of Mesenchymal Stem Cells on Cardiomyocytes

GW24-e1273 Transplantation of Cellular Repressor of E1A-stimulated Gene Modified Embryonic Stem Cells Improves Heart Function Post-Myocardial Infarction Through Blocking MAPK-ERK1/2 Pathway

Heat Shock Protein 90 Stimulates Rat Mesenchymal Stem Cell Migration Via PI3K/Akt and ERK1/2 Pathways

Prolyl Hydroxylase Inhibitor Dimethyloxalylglycine Enhances Mesenchymal Stem Cell Survival

Erythropoietin signal pathway is upregulated in mesenchymal stem cell during hypoxia

ASSA14-03-28 Cellular repressor of E1A-stimulated genes improves heart function in a mouse model of MI

The Experimental research of cellular repressor of E1A-stimulated genes (CREG) inhibiting apoptosis induced by hydrogen peroxide in bone marrow mesenchymal cells

CREG Protects from Myocardial Ischemia/reperfusion Injury by Regulating Myocardial Autophagy and Apoptosis.

The Antiapoptotic Effect of Mesenchymal Stem Cell Transplantation on Ischemic Myocardium is Enhanced by Anoxic Preconditioning.

Angiopoietin-1 Protects Mesenchymal Stem Cells Against Serum Deprivation and Hypoxia-Induced Apoptosis Through the PI3K/Akt Pathway

UP-REGULATION OF ENDOGENOUS LEPTIN IMPROVES HUMAN MESENCHYMAL STEM CELL SURVIVAL ABILITY IN VITRO AND THIS CELLS PROTECT FATAL CARDIAL MYOCYTES FROM APOPTOSIS

Cellular Repressor of E1A-stimulated Genes Inhibits Human Vascular Smooth Muscle Cell Apoptosis Via Blocking P38/JNK MAP Kinase Activation.

Ghrelin Improves Functional Survival of Engrafted Adipose-Derived Mesenchymal Stem Cells in Ischemic Heart Through PI3K/Akt Signaling Pathway.

SRT1720 Pretreatment Promotes Mitochondrial Biogenesis of Aged Human Mesenchymal Stem Cells and Improves Their Engraftment in Postinfarct Nonhuman Primate Hearts.

Modulating autophagy in mesenchymal stem cells effectively protects against hypoxia- or ischemia-induced injury

High Density Lipoprotein Protects Mesenchymal Stem Cells from Oxidative Stress-Induced Apoptosis Via Activation of the PI3K/Akt Pathway and Suppression of Reactive Oxygen Species